Annals of Hepatology

Aims & Scope

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur.

It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH).

AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV).

Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,500.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Bile Acid Physiology

  Citation: 418

  Authors: Agostino, Gabriella, Raquel, Emilio, Leonilde, David Q.-H., Piero

• A multisociety Delphi consensus statement on new fatty liver disease nomenclature

  Citation: 392

  Authors: Mary E., Jeffrey V., Vlad, Sven M., Arun J., Fasiha, Diana, Manal F., Quentin M., Juan Pablo, Marco, Ramon, Ulrich, Jerome, Elisabetta, Christopher D., Graciela E. Castro, Abhijit, Helena, Donna R., Kenneth, Mohamed, Samuel, Wayne, Jiangao, Samer, Cynthia D., Stephen A., Seung Up, Bart G., Marko, Kris V., Florence, Rohit, Robert, Timothy R., Elisabeth E., Michael, Manuel, Marcelo, Shivaram Prasad, Silvia C., C. Wendy, Dina, Luca, Miriam B., Vincent Wai-Sun, Stavra, Yusuf, Zobair, Ansley, Marcela, Philip N.

• Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study

  Citation: 268

  Authors: Vincent Wai-Sun, Grace Lai-Hung, Angel Mei-Ling, Winnie Chiu-Wing, David Ka-Wai, Kevin Chi-To, Henry Lik-Yuen

• Prevalence of non-alcoholic fatty liver disease: population based study

  Citation: 263

  Authors: Deepak, Prafull, Nikhil, Parijat, Pravin, Subhash, Rajiv, Somesh, Dinesh, Anjali

• AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis

  Citation: 231

  Authors: Aurora, Francisco, Edgar, Francisco, Florencia

• Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)

  Citation: 226

  Authors: Stefano, Mariano

• The Role of the Gut Microbiota in Bile Acid Metabolism

  Citation: 211

  Authors: Oscar, Vania, Paulina, Nahum

• Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport

  Citation: 203

  Authors: Helen H., Gabriella, Min, Piero, David Q.-H.

• Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens

  Citation: 196

  Authors: Ylse, Guadalupe, Martha H., Misael, Nahum

• S-adenosylmethionine metabolism and liver disease

  Citation: 167

  Authors: José M., M. Luz, Shelly C.